Fortive Corporation Common Stock vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Fortive Corporation Common Stock trades at $56.51 (market cap $17.07B), while Iovance Biotherapeutics Inc. Common Stock trades at $13.36 (market cap $5.85B). The key difference: Fortive Corporation Common Stock is far larger — about 2.9× Iovance Biotherapeutics Inc. Common Stock's market cap, and Fortive Corporation Common Stock pays a 0.5% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fortive Corporation Common Stock for 0 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| FTV | IOVA | |
|---|---|---|
Market Cap | $17.07B | $5.85B |
Volume | 1,773,097 | 14,517,176 |
Sector | Technology | Health |
52-Week High | $64.09 | $14.82 |
52-Week Low | $47.80 | $1.81 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $20.21B | $5.78B |
Dividend Yield | 0.5% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Fortive provides industrial and healthcare technology solutions. Its products and software support measurement, maintenance, worker safety, instrument sterilization, and clinical workflows.
Read more on FTV →Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →